Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis.

ABSTRACT:

SUBMITTER: Yi JH 

PROVIDER: S-EPMC7968880 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature